Navigation Links
Central Texas Hospital Selects eCareSoft EHR Technology
Date:4/5/2011

AUSTIN, Texas, April 5, 2011 /PRNewswire/ -- eCareSoft announced today the completion of an agreement with Central Texas Hospital (CTH) to connect their network of six hospitals with eCareSoft's inpatient complete EHR and revenue cycle management technology.

CTH will incorporate eCareSoft's proprietary fast-track implementation program enabling their hospital network to expedite their 'meaningful use' activities in order to qualify for 2011-2012 stimulus funds.

"We are very pleased to be a part of Central Texas Hospital's electronic health records strategy," said Jorge Camargo, CEO of eCareSoft.  "Their interest in connecting their six hospitals with our technology is further validation that we are on the right path with our integrated solutions for small hospitals," added Camargo.

Many small and rural hospitals continue to face financial, technical and manpower challenges in transitioning to EHR solutions. eCareSoft offers a turnkey solution of technology, support and training for a fraction of the cost associated with traditional implementations. Using the company's fast-track implementation program, small hospitals can rollout the technology necessary to meet 'meaningful use' in as few as 120 days versus the traditional 8-12 months.

"Transitioning to electronic health records is an important step for us, not only to improve efficiencies across our hospital network, but to advance our goal of providing the highest level of patient care to our communities," stated Joe White, CFO Central Texas Hospital.  "eCareSoft offered us an expedited path to achieving 'meaningful use' and a flexible solution that really seemed to fit our small hospital environments," added White.

eCareSoft's EHR is an ONC-ATCB certified complete inpatient solution that utilizes a shared patient-centric database configuration rather than facilities centric, eliminating the redundant inputting of patient historical information each time an event
'/>"/>

SOURCE eCareSoft
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Approves Gadavist for Central Nervous System Scans
2. U.S. FDA Approves Bayers Gadavistâ„¢ (Gadobutrol) Injection for MRI of the Central Nervous System
3. Mithridion, Inc. Announces New Funding and Outlines Strategy for Central Nervous System Drug Development
4. Reportlinker Adds The Outlook for Pharmaceuticals in Central Asia
5. Regeneron and Bayer Report Positive Results for VEGF Trap-Eye in Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and in Phase 2 Study in Diabetic Macular Edema (DME)
6. Regeneron Schedules December 20, 2010 Teleconference and Webcast to Discuss Results of VEGF Trap-Eye Phase 3 Study in Central Retinal Vein Occlusion (CRVO) and Phase 2 Study in Diabetic Macular Edema (DME)
7. Cipher Pharmaceuticals Using MedAvante Centralized Ratings in Phase 3 Study
8. Rexahn to Use MedAvante Centralized Ratings in MDD Phase 2b Study
9. Wound Management Technologies Adds Panama to Growing List of Distribution Points in Central America
10. FDA Approves NDA That Includes Psychiatric Data Collected by Centralized Raters
11. Reportlinker Adds Drug Delivery in Central Nervous System Diseases - technologies,markets and companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... CLEVELAND , Jan. 14, 2014 NineSigma ... will hold its Innovation Leadership Summit , May ... in Cleveland Ohio . ... innovators and organizations committed to breakthrough achievements through open ...
(Date:1/14/2014)... New York , January 14, 2014 ... Closed System Transfer Devices (CSTD) for hazardous drugs, today announced ... for the fourth straight year.   ... for pharmacy technicians, pharmacists, nurses and other medical ...
(Date:1/14/2014)... Spark Therapeutics , a late-stage gene therapy company, has ... a Phase 3 study for inherited retinal dystrophies caused by mutations ... Marrazzo , is presenting this and other corporate updates today, at ... Francisco . Marrazzo said Spark was able to achieve its ...
Breaking Medicine Technology:Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 2Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 3Expect the Unexpected from Leading Global Innovators at NineSigma Leadership Summit, Sharing Winning Strategies to Advance Innovation 4Equashield's Sales Grow by 60% in 2013 2Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness 2Spark Therapeutics Achieves Recruitment Goal in Phase 3 Gene Therapy Clinical Study for Inherited Blindness 3
... 9, 2011   Endo Pharmaceuticals (Nasdaq: ENDP ) today ... Conference on Tuesday, March 15, 2011 at 3:45 p.m. ET.  Dr. ... the company,s products and development programs. The presentation will ... www.endo.com under the investors section.   ...
... Accumetrics, Inc., a privately-held developer and marketer ... easy-to-use point-of-care system for measuring platelet reactivity to ... were recently published in The Annals of ... platelet reactivity as a new recommendation for preoperative ...
Cached Medicine Technology:2011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery 22011 Surgical Guidelines Recommend Point-of-Care Platelet Reactivity Testing Prior to Surgery 3
(Date:4/24/2014)... prescription opioid overdose deaths was outlined yesterday in the ... of agencies in the U.S. Department of Health and ... providers to expand their use of medications to treat ... number of misperceptions that have limited access to these ... can be used in combination with behavior therapies to ...
(Date:4/24/2014)... An Oregon State University researcher has found a ... the symptoms of autism spectrum disorder in very young ... the first to show a direct relationship between motor ... and gross motor skills should be included in treatment ... an assistant professor in OSU,s College of Public Health ...
(Date:4/23/2014)... frozen stool from healthy, unrelated donors was safe ... diarrhea caused by Clostridium difficile , according ... Clinical Infectious Diseases and available online. Known ... effective whether given via a colonoscope or a ... make this promising treatment more readily available to ...
(Date:4/23/2014)... A Michigan State University researcher is looking to give ... workout, and her latest research shows that a cyber ... the Games for Health Journal , is the ... still a better motivator during exercise, a software-generated partner ... that something that isn,t real can still motivate people ...
(Date:4/23/2014)... that targets an important brain receptor has a dramatic ... relapse behavior, a University at Buffalo animal study has ... may be a novel lead compound for treating cocaine ... research was published as an online preview article in ... the compound, RO5263397, severely blunted a broad range of ...
Breaking Medicine News(10 mins):Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 2Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 3Health News:HHS leaders call for expanded use of medications to combat opioid overdose epidemic 4Health News:Motor skill deficiencies linked to autism severity in new research 2Health News:Pilot study suggests ways to widen access to fecal transplants for C. diff infections 2Health News:Cyber buddy is better than 'no buddy' 2Health News:Novel compound halts cocaine addiction and relapse behaviors 2
... Roxane Laboratories, Inc.,announced today the approval of ... Capsules, 1.25mg, 2.5mg, 5mg and 10mg by ... 2.5mg, 5mg and 10mg strengths will be,available ... are available for immediate shipment to wholesalers ...
... unsure of source; New York City links 7 infections ... -- The number of people known to have fallen ... 383 in 30 states plus the District of Columbia, ... increase is not due to new infections but mainly ...
... continues monitoring and evaluating wrong-site surgeries,with the ... surgery,update, HARRISBURG, Pa., June 18 ... Time Out Day," which is a,national effort ... out" before every,operation to confirm correct patient, ...
... Kevin Max, Ken,Andrews, Joanne Cash and others, ... compilation CD with proceeds benefiting Suicide Awareness Voices ... June 24, 2008. The,release features an exclusive mix ... Kevin Herchen and Max Schnitzer and selections from,Charlotte ...
... DC, June 2008 -- Research findings and innovative approaches ... for cures for adults living with type 1 diabetes, ... (JDRF,s) Global Research Forum in Washington D.C. , Type ... the destruction of insulin-producing beta cells in the pancreas. ...
... irregular heartbeat combine, study finds , , WEDNESDAY, June 18 ... irregular heartbeat called atrial fibrillation can form a deadly ... a less onerous strategy called "rate control" may be ... these circumstances. , "Our results show that one strategy ...
Cached Medicine News:Health News:Roxane Laboratories, Inc. Announces the Launch of Ramipril Capsules 2Health News:Tainted Tomato Cases Jump to 383 People in 30 states, D.C. 2Health News:Tainted Tomato Cases Jump to 383 People in 30 states, D.C. 3Health News:Patient Safety Authority Supports 'National Time Out Day' 2Health News:'Hope, Volume One,' a CD benefiting Suicide Awareness Voices of Education (SAVE), to Be released on June 24, 2008 2Health News:Science, hope for adults with type 1 diabetes focus of JDRF's Annual Global Diabetes Research Forum 2Health News:Science, hope for adults with type 1 diabetes focus of JDRF's Annual Global Diabetes Research Forum 3Health News:Cardiologists Spot Best Treatment for a Deadly Duo 2Health News:Cardiologists Spot Best Treatment for a Deadly Duo 3
... Geometric Data Hemastainer. Formulated to ... quality control tested on human ... staining and absence of precipitate. ... a minimum of eight hours ...
... Unique molecular suspension in methanol ... blood, chromosome, and histology smears. Our ... that rapidly penetrates cellular elements producing ... nuclear detail and unexcelled brilliance in ...
Wright-Giemsa Stain Solutions...
... Stain is ideal for stat, routine or ... smears and bone marrow. Our unique manufacturing ... yield excellent color intensity and morphological differentiation. ... in the Wright's staining procedure and includes ...
Medicine Products: